Jade Biosciences (JBIO) Return on Equity [ROE] (2021 - 2026)
Jade Biosciences (JBIO) posted Return on Equity [ROE] of -41.62% for Q2 2026, up 75.90 percentage points from -117.52% a year earlier but down 0.41 percentage points from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Jade Biosciences' Return on Equity [ROE] came in at -89.19%, up 133.07 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a four-year change of -60.31 percentage points (FY2021 to FY2025).
- In prior years, Jade Biosciences' Return on Equity [ROE] was -222.25% in FY2024 (-158.30 pp), -63.95% in FY2023 (-29.51 pp), -34.44% in FY2022 (-5.57 pp) and -28.87% in FY2021.
- Quarterly Return on Equity [ROE] has run from a low of -194.73% in Q2 2024 to a high of -13.04% in Q4 2021 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2025, with a gain of 77.22 percentage points; the weakest was Q2 2024, with a drop of 144.42 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -41.21% (Q1 2026), -49.78% (Q4 2025) and -41.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Jade Biosciences | 1.04 Bn | -265.30 Mn | - | -41.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.62% |
| Mar 31, 2026 | -41.21% |
| Dec 31, 2025 | -49.78% |
| Sep 30, 2025 | -52.98% |
| Jun 30, 2025 | -155.89% |
| Jun 30, 2024 | -194.73% |
| Mar 31, 2024 | -82.04% |
| Dec 31, 2023 | -64.22% |
| Sep 30, 2023 | -52.40% |
| Jun 30, 2023 | -50.31% |
| Mar 31, 2023 | -47.63% |
| Dec 31, 2022 | -38.75% |
| Sep 30, 2022 | -30.82% |
| Jun 30, 2022 | -23.84% |
| Mar 31, 2022 | -18.60% |
| Dec 31, 2021 | -13.04% |
| Sep 30, 2021 | -23.26% |
API Access
Jade Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();